<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=915327909015523&amp;ev=PageView&amp;noscript=1" target="_blank"> Skip to main content

    The federal government says it will begin a targeted crackdown on nursing homes’ abuse of antipsychotic drugs and misdiagnoses of schizophrenia in patients. The Centers for Medicare and Medicaid Services is launching investigations this month into select nursing homes, aimed at verifying whether patients have been properly diagnosed with the psychiatric disorder. The agency says evidence has mounted over decades that some facilities wrongly diagnose residents with schizophrenia or administer antipsychotic drugs to sedate them, despite dangerous side effects. Health and Human Services Secretary Xavier Becerra said Wednesday no nursing home resident should be “improperly diagnosed with schizophrenia or given an inappropriate antipsychotic.”

    TODAY'S TOP HEADLINES

      Pfizer/BioNTech says a three-dose regimen of its COVID-19 vaccine appears to provoke a strong immune response in the youngest age group of children — those aged 6 months to 5 years.

      This is the only age group not yet approved for COVID-19 vaccination by the U.S. Food and Drug Administration. According to CNN, Pfizer said it plans to submit its new data to the agency this week.

        MARTES, 10 de enero de 2023 (HealthDay News) -- Continuando una tendencia de décadas de longevidad, el porcentaje de mujeres estadounidenses que han tenido alguna vez un hijo se redujo de nuevo en las cifras más recientes de los Centros para el Control y la Prevención de Enfermedades (CDC) de EE. UU.

          MARTES, 10 de enero de 2023 (HealthDay News) -- Cualquiera que haya trabajado en un huerto sabe que cavar en la profundidad de la tierra para plantar semillas, y luego sentirse orgulloso de su primera cosecha, puede ser toda una labor de amor... y una nueva investigación muestra que también mejora la salud.

          Get up-to-the-minute news sent straight to your device.

          Topics

          all